Alcon completes acquisition of Israeli co Belkin Vision

Daria Lemann-Blumenthal credit: Tim Kerr
Daria Lemann-Blumenthal credit: Tim Kerr

Alcon will make an immediate payment of $81 million and a further $385 million in milestone payments, according to the product's success on the market.

The share price of Israeli ophthalmology investment firm BioLight Life Sciences (TASE: BOLT) rose 2% today after Israeli glaucoma treatment company Belkin Vision, in which it holds a 4% stake, announced that it had completed its sale to Swiss-American ophthalmology company Alcon (SWX: ALC).

BioLight reported on the deal in May and since then its share price has risen 40% and it currently has a market cap of NIS 22 million.

Alcon is acquiring Belkin Vision, which has developed laser-based technology for glaucoma treatment for up to $466 million, including an immediate payment of $81 million and a further $385 million in milestone payments according to the product's success on the market.

BioLight will receive NIS 8.9 million cash immediately and payments of up to $10.8 million if Belkin Vision achieves all its milestones - in other words an amount significantly higher than BioLight's overall value. Prior to the announcement of Belkin Vision's acquisition, Biolight had booked the value of its stake at just NIS 3.6 million.

US marketing approval

Last December, Belkin Vision received FDA marketing approval in the US for its laser-based device for treating glaucoma. The company was founded in 2013 as Belkin Laser to develop a non-contact laser treatment that is more effective and accessible in the treatment of glaucoma. In February 2024 Belkin Vision raised $12.3 million, bringing the total amount raised by the company to $40 million. The company has also received a $17.5 million grant from the EU.

The company was founded by ophthalmologist Prof. Michael Belkin as part of Sheba Medical Center's ARC project, together with CEO Daria Lemann-Blumenthal.

Alcon is expected to promote the use of Belkin Vision's product as a first line treatment for glaucoma. Alcon is a leading international corporation in the field of ophthalmology, and in the field of glaucoma it markets eye care and implants, and now it will also add a laser product. The product has been approved for marketing in Europe and the US, but to date has not been marketed in the US.

Published by Globes, Israel business news - en.globes.co.il - on July 3, 2024.

© Copyright of Globes Publisher Itonut (1983) Ltd., 2024.

Daria Lemann-Blumenthal credit: Tim Kerr
Daria Lemann-Blumenthal credit: Tim Kerr
groundcover founders credit: Yossi Yarom Israeli observability co groundcover raises $35m

groundcover has developed a “Bring Your Own Cloud” (BYOC) observability solution, redefining the architecture of a modern observability platform.

Tel Aviv Stock Exchange credit: Shutterstock MagioreStock Foreign investment in TASE hits five-year high

Foreign investors have been flocking to the Tel Aviv Stock Exchange in recent weeks, the TASE research department tells "Globes."

Elbit Systems tank turret systems credit: Elbit Systems Elbit Systems wins $100m tank turret systems deal

The Israel defense electronics company will supply its advanced UT30 MK2 unmanned turret systems to General Dynamics European Land Systems (GDELS) to be supplied to a NATO European country.

Tomer Weingarten Photo: PR Trump targets SentinelOne exec in act of revenge

The US administration has suspended the security clearance of the company's chef intelligence and public policy officer Chris Krebs and everyone associated with him.

Tel Aviv Stock Exchange share prices rising credit: Tali Bogdanovsky TASE opens sharply higher after Trump U-turn on tariffs

The pause is being interpreted as a climb down after US President Donald Trump admitted he had made the move to calm the markets.

Ashot Ashkelon credit: Ministry of Defense Up 250%, Ashot Ashkelon wins another Defense Ministry order

The Israeli defense company's share price has risen 250% in the past three years since FIMI Opportunity Funds acquired control.

Liad Agmon credit: Eyal Izhar Insight Partners Liad Agmon steps down as managing partner

Serial entrepreneur Agmon has served as a partner at Insight Partners Israel alongside Daniel Aronovitz who set up the Israel office.

Shekels credit: Shutterstock Vladerina32 Shekel slide resumes amid escalating tariff war

The Bank of Israel is not expected to intervene in the forex market despite the sharp depreciation of the shekel.

Nir Zuk credit: Inbal Marmari Palo Alto Networks mulls buying AI security co for $700m

Sources inform "Globes" that on Palo Alto's radar is Protect AI.

President Donald Trump hosts Prime Minister Benjamin Netanyahu credit: Reuters Kevin Mohatt Israeli officials confident on US tariff concessions

Senior Israeli figures believe that concessions could be tied to progress on strategic regional political issues that are important to President Trump.

Phoenix Investment House CEO Avner Hadad  credit: Tommy Harpaz "The market has priced in all the bad things"

Phoenix Investment House CEO Avner Hadad says US markets could continue to fall, but that we are close to interesting territory for patient investors.

Tel Aviv credit: Shutterstock Tel Aviv slips in World's Wealthiest Cities ranking

Tel Aviv's position as one of the world's wealthiest cities took a big knock over the past year as it slipped from 42nd to 48th in investment advisors Henley & Co.'s "World's Wealthiest Cities" Top 50 ranking.

Leviathan platform  credit: Albatross C'ttee seen recommending no cut in gas exports

The Dayan committee on the future of the gas sector estimates that Israel's natural gas reserves will run out in 2045.

Accountant General Yali Rothenberg credit: Rafi Kutz Israel's fiscal deficit continues to narrow

The deficit narrowed in the twelve months to the end of March 2025, for the sixth consecutive month, Ministry of Finance accountant general Yali Rothenberg reported today.

Arkia credit: Arkia Arkia cuts Tel Aviv - New York April fares

Arkia has cut fares at the last minute, a time when prices usually soar even higher, according to the pricing method used in the industry.

Bank of Israel Governor Prof. Amir Yaron credit: Dani Shem Tov Knesset Spokesperson BoI Governor: US tariffs could push up inflation in Israel

Prof. Amir Yaron tells "Globes" that there is a risk that the new tariffs will cause inflation to rise in the US, with a knock-on effect for Israel.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018